Yan Leyfman: Episode 3 of The Translational Edge on Cancer Anticoagulation Is Now Live on Shuf
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, Medical Correspondent at OncLive, shared Jeremy Bellaiche‘s post on LinkedIn, adding:
“Episode 3 of The Translational Edge is now live on Shuf.
As oncology care becomes more personalized, one critical question remains:
Are we dosing based on evidence—or outdated assumptions?
This episode explores the evolving science of anticoagulation in cancer patients with obesity—and how aligning practice with data can directly impact outcomes.
Translating breakthroughs into impact.
Jeremy Bellaiche, Founder of Shuf, shared a post on LinkedIn:
“Excited to share the episode 3 of The Translational Edge season 2 with Yan Leyfman exclusively on Shuf !
Treating Blood Clots in Cancer Patients with Obesity: Why Dosing Finally Caught Up with Reality.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC